Skip to main content

Main menu

  • Home
  • Content
    • Early Access
    • Current Issue
    • Kidney360 Podcasts
    • Subject Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Clinical Images
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
    • Editorial Team
    • Editorial Training Program
    • Reviewer Recognition
  • More
    • About Kidney360
    • Advertising
    • Disqus Commenting
    • Email Alerts
    • Feedback
    • Reprint Information
  • ASN Kidney News
  • Other
    • ASN Publications
    • JASN
    • CJASN
    • Kidney News Online
    • American Society of Nephrology

User menu

Search

  • Advanced search
American Society of Nephrology
  • Other
    • ASN Publications
    • JASN
    • CJASN
    • Kidney News Online
    • American Society of Nephrology
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Early Access
    • Current Issue
    • Kidney360 Podcasts
    • Subject Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Clinical Images
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Editorial Team
    • Editorial Team
    • Editorial Training Program
    • Reviewer Recognition
  • More
    • About Kidney360
    • Advertising
    • Disqus Commenting
    • Email Alerts
    • Feedback
    • Reprint Information
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow Kidney360 on Twitter
  • Community Forum
  • Kidney360 RSS
Original Investigation

Proportion of Hemodialysis treatments with High Ultrafiltration Rate and the association with Mortality

José E. Navarrete, Ajai Rajabalan, Jason Cobb and Janice P. Lea
Kidney360 May 2022, 10.34067/KID.0001322022; DOI: https://doi.org/10.34067/KID.0001322022
José E. Navarrete
1Medicine, Emory University, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for José E. Navarrete
  • For correspondence: jnavarr@emory.edu
Ajai Rajabalan
2Nephrology, Emory University, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ajai Rajabalan
Jason Cobb
3Renal Medicine, Emory University School of Medicine, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jason Cobb
Janice P. Lea
4Department of Medicine, Renal Division, Emory University, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • View PDF
Loading

Key Points

  • Episodes of hemodialysis (HD) with high ultrafiltration rate (>13ml/kg/hour) occurred frequently in 1050 incident dialysis patients.

  • Age, diabetes, heart failure, higher albumins, male gender, shorter treatment time and lower weights were associated with high UFR.

  • Increasing number of dialysis sessions with high ultrafiltration rate were associated with higher all-cause and cardiovascular mortality.

Abstract

Background: Rapid fluid removal during hemodialysis has been associated with increased mortality. The limit of ultrafiltration rate (UFR) monitored by the Centers for Medicare and Medicaid Services is 13 ml/kg/hr. It is not clear if the proportion of treatments with high UFR is associated with higher mortality. We examined the association of proportion of dialysis treatments with high UFR and mortality in end stage kidney failure patients receiving hemodialysis Methods: retrospective study of incident patients initiating hemodialysis between January 1, 2010 to December 31, 2019 at Emory dialysis centers. The proportion of treatments with high UFR (>13ml/kg/hr) per patient was calculated using data from the initial 3 months of dialysis therapy. Patients were categorized based on quartiles of proportion of dialysis sessions with high UFR. Risk of death and survival probabilities were calculated and compared for all quartiles. Results: Of 1050 patients eligible, the median age was 59 years, 56% were male and 91% were black. The median UFR was 6.5 ml/kg/hr and the proportion of sessions with high UFR was 5%. 31% of patients never experienced high UFR. Male gender, younger age, shorter duration of hemodialysis sessions, lower weight, diabetic status, higher albumin and history of heart failure were associated with higher proportion of sessions with high UFR. Patients in the higher quartile (26% dialysis with high UFR, average UFR 9.8ml/kg/hr, median survival of 5.6 years) had a higher risk of death (adjusted hazard-ratio 1.54, CI: 1.13-2.10) compared to those in the lower quartile (0% dialysis with high UFR, average UFR 4.7ml/kg/hr, median survival 8.8 years). Conclusions: Hemodialysis patients that did not experience frequent episodes of elevated UFR during the first three months of their dialysis tenure had a significantly lower risk of death compared to patients with frequent episodes of high UFR.

  • ultrafiltration rate
  • hemodialysis
  • mortality risk
  • Received February 14, 2022.
  • Revision received May 2, 2022.
  • Accepted May 2, 2022.
  • Copyright © 2022 American Society of Nephrology
PreviousNext
Back to top

In this issue

Kidney360: 3 (4)
Kidney360
Vol. 3, Issue 4
28 Apr 2022
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • About the Cover
  • Index by author
View Selected Citations (0)
Download PDF
Sign up for Alerts
Email Article

Thank you for your interest in spreading the word on American Society of Nephrology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Proportion of Hemodialysis treatments with High Ultrafiltration Rate and the association with Mortality
(Your Name) has sent you a message from American Society of Nephrology
(Your Name) thought you would like to see the American Society of Nephrology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Mortality and proportion of hemodialysis with high UFR
José E. Navarrete, Ajai Rajabalan, Jason Cobb, Janice P. Lea
Kidney360 May 2022, 10.34067/KID.0001322022; DOI: 10.34067/KID.0001322022

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
Mortality and proportion of hemodialysis with high UFR
José E. Navarrete, Ajai Rajabalan, Jason Cobb, Janice P. Lea
Kidney360 May 2022, 10.34067/KID.0001322022; DOI: 10.34067/KID.0001322022
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
  • Info & Metrics
  • View PDF

More in this TOC Section

  • K+ and PO4- in AKI-RRT in COVID-19
  • Diabetic Eye and Haemodialysis
  • Age bleeding risk in dialysis on P2Y12I
Show more Original Investigation

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Related Articles

  • No related articles found.
  • Google Scholar

Keywords

  • ultrafiltration rate
  • hemodialysis
  • mortality risk

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Author Resources
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • Kidney360
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About Kidney360
  • Kidney360 Email Alerts
  • Kidney360 Podcasts
  • Kidney360 RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Subscribe to JASN and CJASN

© 2022 American Society of Nephrology

Online ISSN - 2641-7650

Powered by HighWire